The FDA’s Emergency Use Authorization (EUA) allows Covid-19 vaccines and therapeutics to enter the market quicker than the usual pathway of full licensure. But as the government and the public look to shift into an endemic state, questions arise as to the future of this...
Jorge Osorio, an expert in epidemiology, virology and vaccines, has been named the next director of the University of Wisconsin–Madison’s Global Health Institute....
The pandemic shed light on the importance of addressing health equity in a variety of ways....
Moderna announced Thursday morning that it's asking the FDA to approve its COVID vaccine for kids under 6 years old. If authorized for emergency use, it would become the first eligible vaccine for kids younger than 5....
Artificial Intelligence (AI) has the power to ensure clinical trials are unbiased from the outset and draw better inferences about the different responses between men and women from clinical trials....
In honor of “Medical Laboratory Professionals Week” (April 24-30), we at the University of Wisconsin–Madison Clinical Research Office would like to express our gratitude to all of the lab professionals in our clinical research community!...
Early clinical trials suggest vaccines that activate T cells work better and faster and may protect people with weakened immune systems....
Through the support of renowned alum Leon Lachman, the Institute harnesses expertise and enhances collaboration to move pharmaceutical therapies from the lab into the clinic....
What can we expect to see from decentralized trials in the next three years, and what are the challenges sponsor companies will need to overcome?...
We must apply lessons learned in the development of the COVID-19 vaccines, including community engagement strategies and innovative clinical trial design, to longstanding public health challenges such as TB....
